Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Hepa/Biliary Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Hepa/Biliary Other
    Changes Not Affecting Tumour Size May Better Predict Outcomes to Bevacizumab: Presented at RSNA - (DGDispatch)
    Adding Cetuximab to Chemotherapy Increases Tumour Shrinkage In Advanced Colorectal Cancer - (DGNews)
    New Drug Regimen Shows Promising Results for Advanced Biliary-Tract Cancers - (DGNews)
    Statin use and risk of gallstone disease followed by cholecystectomy - (JAMA)
    What Is the Optimal Timing of Hepatitis C Antiviral Therapy Before and After Liver Transplantation? Presented at AASLD - (DGDispatch)

    News archive

     Recent webcasts/CME - Hepa/Biliary Other
    • Active Ulcerative Colitis: Selection of First-Line Therapies for Better Patient Outcomes
    • Alpha1-Antitrypsin Augmentation: Approaches and Benefits
      Drug-Induced Liver Disease, Part 2
      Drug-Induced Liver Disease, Part 1
      The Meso-Rex Bypass for Portal Hypertension in Children

      Webcasts/CME archive

       Recent cases - Hepa/Biliary Other
        Acute Cholangitis Due To Pancreatic Metastasis From Squamous Cell Lung Carcinoma: A Case Report And Review Of Literature
        A Latent Form Of Essential Thrombocythemia Presenting As Portal Cavernoma
        Liver Abscess And Sepsis With Bacillus Pantothenticus In An Immunocompetent Patient: A First Case Report
        Abscess of the Round Ligament of the Liver Associated with Acute Obstructive Cholangitis and Septic Thrombosis
        An Atypical Case of Hepatic Cavernous Hemangioma: A Case Report

        Cases archive
          




        my personal edition > hepa/biliary other > news
        divider

          E-Mail this DGDispatch to a colleague

        DGDispatch


        Alcohol Does Not Appear to Increase Acetaminophen-Related Acute Liver Failure: Presented at AASLD

        By Cheryl Lathrop

        BOSTON -- November 2, 2009 -- While alcohol use is common in acetaminophen-related acute liver failure (ALF), it does not appear to increase acetaminophen-related mortality or the need for liver transplantation, according to research presented here at the Liver Meeting 2009, the 60th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD).

        Alcohol users, however, have lower acetaminophen levels, higher aspartate aminotransferase (AST), renal insufficiency, and higher Model for End-Stage Liver Disease (MELD) scores than nonusers, noted Lulu Iles-Shih, MD, Oregon Health and Sciences University, Portland, Oregon, speaking here at a poster session on October 31.

        Acetaminophen is the most common cause of ALF in the United States. Although alcohol can potentiate hepatotoxicity, its impact on the outcome of acetaminophen-related ALF was unknown. The aim of this study was to assess the association between alcohol use and adverse outcomes. The hypothesis was that individuals who consume alcohol do indeed have worse outcomes than those that do not. The authors, however, decided that alcohol does not appear to increase acetaminophen-related mortality or the need for liver transplantation.

        Dr. Iles-Shih and colleagues examined 622 subjects (74% female) with acetaminophen-related ALF who had enrolled in the prospective US Acute Liver Failure Study (January 1998 to November 2008). Binary logistic regression was used to characterise the effect of alcohol on rates of death or liver transplantation (after controlling for confounders).

        Data regarding alcohol use were available for 99% of patients: 51.2% (n = 315) consumed alcohol. The amount of alcohol was quantified in 56% of this group of consumers -- the median alcohol consumed was 40 g/day; the mean alcohol consumed was 69.4 g/day (range 10 to 1,000 g). It was noted that females were less likely to drink alcohol; there were 67.7% females in the alcohol group and 82.7% females in the non-alcohol group.

        Death occurred in 25.2% (n = 157) of subjects, and 8.4% (n = 52) had a liver transplant.

        Alcohol users had a higher admission creatinine (2.68 mg/dL [standard error {SE} +- 0.1] vs 2.34 mg/dL [SE +- 0.13]), higher AST (6,701 IU/L +- 428 vs 4,696 IU/L +- 258), higher MELD scores (32.3 vs 29.7), and lower acetaminophen levels (52.4 mg/L +- 4.01 vs 76.7 +- 6.75) than non-alcohol users.

        No differences were observed in age, race, international normalised ratio upon admission, body mass index, mean arterial pressure, or mode of toxicity (intentional or unintentional).

        [Presentation title: Role of Alcohol in Acetaminophen-Related Acute Liver Failure. Abstract 272]




        E-Mail this DGDispatch to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send